{"id":12298,"date":"2026-05-09T15:21:34","date_gmt":"2026-05-09T15:21:34","guid":{"rendered":"https:\/\/www.elbonifit.com\/?post_type=product&#038;p=12298"},"modified":"2026-05-09T17:58:38","modified_gmt":"2026-05-09T17:58:38","slug":"tirzepatide-glp-2-20-mg","status":"publish","type":"product","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg","title":{"rendered":"Tirzepatide GLP-2  20 mg"},"content":{"rendered":"<ul class=\"elementor-icon-list-items\">\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">Physical profile: Lyophilized powder<\/span><\/li>\n<li class=\"elementor-icon-list-item\"><span class=\"elementor-icon-list-text\">This product is sold as a research chemical and not for human or animal consumption. For laboratory use by qualified professionals.<\/span><\/li>\n<li>No returns accepted<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-content-1171\" class=\"elementor-tab-content elementor-clearfix elementor-active\" role=\"region\" data-tab=\"1\" aria-labelledby=\"elementor-tab-title-1171\">\n<h2>Buy GLP-2 (TRZ) 20mg Research Peptide Online<\/h2>\n<p>This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations.<\/p>\n<h3>Peptide Identification &amp; Structural Engineering<\/h3>\n<p>The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics.<\/p>\n<h3>Mechanism of Action in Laboratory Systems<\/h3>\n<p>Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology.<\/p>\n<h3>Published Research Summary<\/h3>\n<p>Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses.<\/p>\n<h3>Specifications &amp; Handling<\/h3>\n<p>Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature.<\/p>\n<h3>GLP-2 (TRZ) Research Use Only Disclaimer<\/h3>\n<p>For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies.<\/p>\n<\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1172\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"2\" aria-controls=\"elementor-tab-content-1172\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Protocol<\/a><\/div>\n<\/div>\n<div class=\"elementor-accordion-item\">\n<div id=\"elementor-tab-title-1173\" class=\"elementor-tab-title\" role=\"button\" data-tab=\"3\" aria-controls=\"elementor-tab-content-1173\" aria-expanded=\"false\"><a class=\"elementor-accordion-title\" tabindex=\"0\">Clinical Research<\/a><\/div>\n<\/div>\n","protected":false},"featured_media":12314,"comment_status":"open","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_joinchat":[]},"product_brand":[],"product_cat":[16],"product_tag":[],"class_list":["post-12298","product","type-product","status-publish","has-post-thumbnail","product_cat-uncategorized","first","instock","taxable","shipping-taxable","purchasable","product-type-simple"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification &amp; Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"es_ES\" \/>\n\t\t<meta property=\"og:site_name\" content=\"BONIFIT - BIENVENIDOS\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Tirzepatide GLP-2 20 mg - BONIFIT\" \/>\n\t\t<meta property=\"og:description\" content=\"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification &amp; Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"831\" \/>\n\t\t<meta property=\"og:image:height\" content=\"833\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-05-09T15:21:34+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-05-09T17:58:38+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Tirzepatide GLP-2 20 mg - BONIFIT\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification &amp; Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.elbonifit.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"position\":2,\"name\":\"TIENDA\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"position\":3,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#listItem\",\"name\":\"Tirzepatide GLP-2  20 mg\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?page_id=31#listItem\",\"name\":\"TIENDA\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#listItem\",\"position\":4,\"name\":\"Tirzepatide GLP-2  20 mg\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product_cat=uncategorized#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"ItemPage\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#itempage\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg\",\"name\":\"Tirzepatide GLP-2 20 mg - BONIFIT\",\"description\":\"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification & Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications & Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\\u00b0C (long-term), 4\\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research\",\"inLanguage\":\"es-ES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#breadcrumblist\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/IMG-20260509-WA0019-scaled.jpg\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg\\\/#mainImage\",\"width\":2560,\"height\":2333},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg#mainImage\"},\"datePublished\":\"2026-05-09T15:21:34+00:00\",\"dateModified\":\"2026-05-09T17:58:38+00:00\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/cropped-bonifit.with-white-2.png\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg\\\/#organizationLogo\",\"width\":831,\"height\":833},\"image\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/?product=tirzepatide-glp-2-20-mg\\\/#organizationLogo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#website\",\"url\":\"https:\\\/\\\/www.elbonifit.com\\\/\",\"name\":\"BONIFIT\",\"description\":\"BIENVENIDOS\",\"inLanguage\":\"es-ES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.elbonifit.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Tirzepatide GLP-2 20 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification & Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications & Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","canonical_url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","position":1,"name":"Home","item":"https:\/\/www.elbonifit.com","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","position":2,"name":"TIENDA","item":"https:\/\/www.elbonifit.com\/?page_id=31","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","position":3,"name":"Uncategorized","item":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized","nextItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#listItem","name":"Tirzepatide GLP-2  20 mg"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?page_id=31#listItem","name":"TIENDA"}},{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#listItem","position":4,"name":"Tirzepatide GLP-2  20 mg","previousItem":{"@type":"ListItem","@id":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized#listItem","name":"Uncategorized"}}]},{"@type":"ItemPage","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#itempage","url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg","name":"Tirzepatide GLP-2 20 mg - BONIFIT","description":"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification & Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications & Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","inLanguage":"es-ES","isPartOf":{"@id":"https:\/\/www.elbonifit.com\/#website"},"breadcrumb":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#breadcrumblist"},"image":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2026\/05\/IMG-20260509-WA0019-scaled.jpg","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg\/#mainImage","width":2560,"height":2333},"primaryImageOfPage":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg#mainImage"},"datePublished":"2026-05-09T15:21:34+00:00","dateModified":"2026-05-09T17:58:38+00:00"},{"@type":"Organization","@id":"https:\/\/www.elbonifit.com\/#organization","name":"BONIFIT","description":"BIENVENIDOS","url":"https:\/\/www.elbonifit.com\/","logo":{"@type":"ImageObject","url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-2.png","@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg\/#organizationLogo","width":831,"height":833},"image":{"@id":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg\/#organizationLogo"}},{"@type":"WebSite","@id":"https:\/\/www.elbonifit.com\/#website","url":"https:\/\/www.elbonifit.com\/","name":"BONIFIT","description":"BIENVENIDOS","inLanguage":"es-ES","publisher":{"@id":"https:\/\/www.elbonifit.com\/#organization"}}]},"og:locale":"es_ES","og:site_name":"BONIFIT - BIENVENIDOS","og:type":"article","og:title":"Tirzepatide GLP-2 20 mg - BONIFIT","og:description":"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification &amp; Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","og:url":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg","og:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:secure_url":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png","og:image:width":831,"og:image:height":833,"article:published_time":"2026-05-09T15:21:34+00:00","article:modified_time":"2026-05-09T17:58:38+00:00","twitter:card":"summary_large_image","twitter:title":"Tirzepatide GLP-2 20 mg - BONIFIT","twitter:description":"Buy GLP-2 (TRZ) 20mg Research Peptide Online This higher-concentration preparation supports pharmacodynamic saturation studies and long-term preclinical protocols requiring sustained receptor occupancy. The 20mg single-dose format enables investigation of dose-ceiling effects and comparative tissue adaptation responses across extended study durations. Peptide Identification &amp; Structural Engineering The TRZ-designated GLP-2 agonist exemplifies modern peptide pharmaceutical chemistry through targeted amino acid substitution strategies. Structural modifications enhance resistance to intestinal brush-border peptidases and serum proteases identified in animal toxicokinetic studies. Biophysical characterization confirms stable alpha-helical secondary structure maintained through synthetic construction, supporting predictable receptor interaction kinetics. Mechanism of Action in Laboratory Systems Preclinical evidence demonstrates that GLP-2 receptor agonist administration activates enteric neural pathways controlling gastrointestinal motility and blood flow regulation. Electrophysiological recordings from isolated intestinal preparations show enhanced smooth muscle contractility patterns consistent with enhanced neural input. Molecular studies reveal increased expression of neurotrophic factors (GDNF, NGF) in treated intestinal segments, suggesting potential for investigating enteric nervous system physiology. Published Research Summary Drucker et al. (Diabetes, 2004) established detailed pharmacodynamic profiles for various GLP-2 analogs in animal models, including TRZ-class compounds. Pettersson et al. (Cell Metabolism, 2006) characterized metabolic phenotypes following GLP-2 agonist administration, showing intestinal-specific adaptations without systemic metabolic alterations. These studies validate 20mg-scale investigations for mechanistic characterization of receptor-mediated responses. Specifications &amp; Handling Form: Lyophilized powder; Quantity: 20mg; Solvent: Sterile PBS or normal saline; Reconstitution: Gentle dissolution over 15-20 minutes; Storage: -20\u00b0C (long-term), 4\u00b0C (up to 7 days); Stability: 18-24 months if maintained at proper temperature. GLP-2 (TRZ) Research Use Only Disclaimer For research use only. Not for human consumption or clinical application. This product has not been evaluated by regulatory agencies. Protocol Clinical Research","twitter:image":"https:\/\/www.elbonifit.com\/wp-content\/uploads\/2024\/02\/cropped-bonifit.with-white-1.png"},"aioseo_meta_data":{"post_id":"12298","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"ItemPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2026-05-09 15:21:35","updated":"2026-05-18 05:04:14","ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?page_id=31\" title=\"TIENDA\">TIENDA<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.elbonifit.com\/?product_cat=uncategorized\" title=\"Uncategorized\">Uncategorized<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tTirzepatide GLP-2  20 mg\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.elbonifit.com"},{"label":"TIENDA","link":"https:\/\/www.elbonifit.com\/?page_id=31"},{"label":"Uncategorized","link":"https:\/\/www.elbonifit.com\/?product_cat=uncategorized"},{"label":"Tirzepatide GLP-2  20 mg","link":"https:\/\/www.elbonifit.com\/?product=tirzepatide-glp-2-20-mg"}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12298","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12298"}],"version-history":[{"count":1,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12298\/revisions"}],"predecessor-version":[{"id":12300,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/product\/12298\/revisions\/12300"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=\/wp\/v2\/media\/12314"}],"wp:attachment":[{"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12298"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=12298"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=12298"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/www.elbonifit.com\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=12298"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}